Amanote Research
Register
Sign In
Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease
doi 10.1021/jm060207o.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Protease-Mediated Enhancement of Severe Acute Respiratory Syndrome Coronavirus Infection
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Severe Acute Respiratory Syndrome Coronavirus
Diarylheptanoids From Alnus Japonica Inhibit Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Identification of a Novel Protein 3a From Severe Acute Respiratory Syndrome Coronavirus
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
Critical Assessment of Important Regions in the Subunit Association and Catalytic Action of the Severe Acute Respiratory Syndrome Coronavirus Main Protease
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Structure-Based Design of Novel HIV-1 Protease Inhibitors to Combat Drug Resistance
Interactions Between M Protein and Other Structural Proteins of Severe, Acute Respiratory Syndrome-Associated Coronavirus
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes
Acute Renal Impairment in Coronavirus-Associated Severe Acute Respiratory Syndrome
Kidney International
Nephrology
Structure of Severe Acute Respiratory Syndrome Coronavirus Receptor-Binding Domain Complexed With Neutralizing Antibody
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
